Gene therapy: towards a one-time cure for β-thalassemia
Thalassemia is a highly prevalent monogenic inherited hemolytic disease in southern China, typically caused by defects in the β-globin gene or α-globin gene that disrupt hemoglobin synthesis. China has over 30 million carriers of thalassemia genes, among whom about 300, 000 are patients with severe...
Furkejuvvon:
| Váldodahkki: | |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Chinês |
| Almmustuhtton: |
Editorial Office of Journal of Guangxi Medical University
2025-10-01
|
| Ráidu: | Guangxi Yike Daxue xuebao |
| Fáttát: | |
| Liŋkkat: | https://journal.gxmu.edu.cn/article/doi/10.16190/j.cnki.45-1211/r.2025.05.001 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|